Amphotericin less toxic in fat emulsion

Area of Science:

• Pharmacology
• Clinical Toxicology

Background:

• Amphotericin is a critical antifungal medication.
• Dextrose formulations of amphotericin are associated with significant clinical and renal toxicity.
• Alternative delivery methods are needed to mitigate amphotericin-associated adverse events.

Purpose of the Study:

• To evaluate the potential of fat emulsion formulations to reduce amphotericin toxicity.
• To compare the safety profile of amphotericin delivered in fat emulsion versus dextrose.

Main Methods:

• Preclinical or clinical studies comparing amphotericin in fat emulsion versus dextrose.
• Assessment of key toxicity markers, including renal function and clinical adverse events.

Main Results:

• Fat emulsion formulation of amphotericin demonstrated reduced clinical toxicity compared to dextrose.
• Renal toxicity was significantly lower when amphotericin was administered in a fat emulsion.

Conclusions:

• Formulating amphotericin in a fat emulsion represents a promising strategy to minimize its toxicity.
• This approach may enhance the therapeutic index of amphotericin, improving patient safety.